Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 USD | -0.34% | -4.95% | -29.33% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
ETFs positioned on CureVac N.V.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 0 M€ | +3.67% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.33% | 667M | |
+18.03% | 47.02B | |
+48.77% | 41.86B | |
+0.84% | 41.76B | |
-4.27% | 28.8B | |
+11.90% | 26.05B | |
-21.50% | 19.15B | |
+4.24% | 12.55B | |
+28.43% | 12.34B | |
-4.33% | 11.82B |
- Stock Market
- Equities
- CVAC Stock
- Funds and ETFs CureVac N.V.